Sale!

MT-TW Gene Encephalopathy mitochondrial MT-TW related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

**MT-TW Gene Encephalopathy: Mitochondrial MT-TW Related Genetic Test at DNA Labs UAE**

The MT-TW gene encephalopathy genetic test, available at DNA Labs UAE, is a specialized diagnostic tool designed to detect mutations in the MT-TW gene, which is known to be associated with mitochondrial disorders. The MT-TW gene is crucial for mitochondrial function, playing a significant role in the synthesis of mitochondrial tRNAs necessary for protein production within the mitochondria. Mutations in this gene can lead to a variety of mitochondrial encephalopathies, which are complex neurological disorders characterized by a wide range of symptoms, including muscle weakness, neurodevelopmental delays, seizures, and other systemic manifestations.

The test is conducted through a detailed analysis of the patient’s DNA to identify any genetic alterations in the MT-TW gene that might be responsible for mitochondrial dysfunction. This genetic testing is pivotal for the accurate diagnosis and management of mitochondrial encephalopathies, enabling healthcare providers to tailor treatment plans to the specific needs of the patient based on their genetic makeup.

At DNA Labs UAE, the MT-TW gene encephalopathy genetic test is priced at 4400 AED. The cost reflects the sophisticated technology and expertise required to accurately identify mutations in the mitochondrial DNA and provide critical insights into the patient’s condition. The test is recommended for individuals exhibiting symptoms of mitochondrial disorders or those with a family history of such conditions, as early detection and intervention can significantly improve patient outcomes.

DNA Labs UAE is equipped with state-of-the-art facilities and staffed by a team of genetic experts committed to providing high-quality diagnostic services. By opting for the MT-TW gene encephalopathy genetic test at DNA Labs UAE, patients and their families can take a crucial step towards understanding their genetic health and navigating the complexities of mitochondrial disorders with informed confidence.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MT-TW Gene Encephalopathy mitochondrial MT-TW related Genetic Test

Genetic testing is an important tool in diagnosing and understanding genetic disorders. One such disorder is MT-TW gene encephalopathy mitochondrial, which affects the function of mitochondria, the energy-producing structures in cells.

This rare genetic disorder is caused by mutations in the MT-TW gene, which provides instructions for making a specific mitochondrial transfer RNA molecule. The MT-TW gene is located in the mitochondrial DNA and is inherited maternally.

At DNA Labs UAE, we offer a comprehensive MT-TW gene encephalopathy mitochondrial MT-TW related genetic test. This test utilizes Next-Generation Sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes.

The MT-TW related NGS genetic test involves obtaining a sample of DNA, typically from a blood sample. Our team of experts will then analyze the sample using NGS technology to detect mutations in the MT-TW gene that are associated with encephalopathy mitochondrial.

Our MT-TW gene encephalopathy mitochondrial MT-TW related genetic test is performed in our Genetics department by our experienced Neurologist. The test is specifically designed for individuals with neurological disorders.

The cost of the MT-TW gene encephalopathy mitochondrial MT-TW related genetic test is 4400.0 AED. We accept samples in the form of blood or extracted DNA, or even one drop of blood on an FTA card.

Once the sample is received, the report delivery time is typically 3 to 4 weeks. During this time, our team will thoroughly analyze the sample and provide a detailed report.

Prior to the test, it is important to provide us with the clinical history of the patient who is going for the MT-TW gene encephalopathy mitochondrial MT-TW related NGS genetic DNA test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the disorder.

By undergoing the MT-TW gene encephalopathy mitochondrial MT-TW related genetic test, individuals can confirm a diagnosis, make informed treatment decisions, and gain insight into the risk of passing the condition on to future generations.

Test Name MT-TW Gene Encephalopathy mitochondrial MT-TW related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MT-TW Gene Encephalopathy mitochondrial, MT-TW related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TW Gene Encephalopathy mitochondrial, MT-TW related
Test Details

MT-TW gene encephalopathy mitochondrial is a rare genetic disorder that affects the function of the mitochondria, the energy-producing structures in cells. This disorder is caused by mutations in the MT-TW gene, which provides instructions for making a specific mitochondrial transfer RNA molecule. The MT-TW gene is located in the mitochondrial DNA, which is inherited maternally.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes simultaneously. NGS can be used to identify mutations in the MT-TW gene that cause encephalopathy mitochondrial.

The MT-TW related NGS genetic test involves obtaining a sample of DNA, typically from a blood sample, and analyzing it using NGS technology. The test can detect mutations in the MT-TW gene that are associated with encephalopathy mitochondrial. This information can be used to confirm a diagnosis, inform treatment decisions, and provide information about the risk of passing the condition on to future generations.